Deals
25 August 2023, 4:38 pm 1 minute
Reuters exclusively reported that Danaher Corp (DHR.N) is in the lead to acquire Abcam Plc, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings.
Market Impact
Abcam shares rose as much as 9% in afternoon trading in New York on Friday to $24.52. Danaher shares were up 1.3% at $256.76.
Article Tags
Topics of Interest: Deals
Type: Reuters Best
Sectors: Business & Finance
Regions: AmericasEurope
Countries: EnglandUnited States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
https://www.reutersagency.com/en/reutersbest/article/danaher-in-the-lead-to-acquire-biomedical-equipment-vendor-abcam/